Volume 40; Issue supp-S2

Main
Seminars in Hematology
Volume 40; Issue supp-S2

Seminars in Hematology

Volume 40; Issue supp-S2

1

Chronic myeloid leukemia in the imatinib era

Brian J. Druker

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 50 KB

english, 2003

2

Molecular mechanisms of transformation by the BCR-ABL oncogene

Martin Sattlermc, James D. Griffin

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 148 KB

english, 2003

3

Towards combination target-directed chemotherapy for chronic myeloid leukemia: Role of farnesyl transferase inhibitors

George Q. Daley

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 67 KB

english, 2003

4

Imatinib: A targeted clinical drug development

Renaud Capdeville, Sandra Silberman

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 123 KB

english, 2003

5

Imatinib treatment: Specific issues related to safety, fertility, and pregnancy

Martee L. Hensley, John M. Ford

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 81 KB

english, 2003

6

Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy

Daniela Cilloni, Giuseppe Saglio

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

7

Prediction of response to imatinib by cDNA microarray analysis

Ryuzo Ohno, Yusuke Nakamura

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

8

The cytogenetic response as a surrogate marker of survival

Gianantonio Rosti, Nicoletta Testoni, Giovanni Martinelli, Michele Baccarani

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 124 KB

english, 2003

9

Cytogenetic studies in patients on imatinib

Michael W.N. Deininger

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 93 KB

english, 2003

10

Molecular monitoring of chronic myeloid leukemia

Tim Hughes, Susan Branford

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 129 KB

english, 2003

11

Cytogenetic and molecular mechanisms of resistance to imatinib

Andreas Hochhaus

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 287 KB

english, 2003

12

Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment

Catherine Roche-Lestienne, Claude Preudhomme

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 59 KB

english, 2003

13

Imatinib mesylate in combination with other chemotherapeutic drugs: In vitro studies

Alex J. Tipping, Junia V. Melo

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 104 KB

english, 2003

14

Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials

François Guilhot, Martine Gardembas, Philippe Rousselot, Michel Tulliez, Magda Vigier, Agnès Buzyn, Françoise Rigal-Huguet, Laurence Legros, Mauricette Michallet, Christian Berthou, Albert Najman, Fre

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 82 KB

english, 2003

15

Clinical decisions for chronic myeloid leukemia in the imatinib era

John M. Goldman, David Marin, Eduardo Olavarria, Jane F. Apperley

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 93 KB

english, 2003

16

Comments on the Hammersmith policy

Michele Baccarani

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 38 KB

english, 2003

17

Comments on the Hammersmith policy

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 46 KB

english, 2003

18

Comments on the Hammersmith policy

George Q. Daley

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 39 KB

english, 2003

19

Comments on the Hammersmith policy

Brian J. Druker

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 48 KB

english, 2003

20

Comments on the Hammersmith policy

François Guilhot

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 48 KB

english, 2003

21

Comments on the Hammersmith policy

Andreas Hochhaus

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 47 KB

english, 2003

22

Comments on the Hammersmith policy

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 48 KB

english, 2003

23

Comments on the Hammersmith policy

Francois-Xavier Mahon

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 46 KB

english, 2003

24

Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia

Stephen G. O'Brien, Michael W.N. Deininger

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 99 KB

english, 2003

25

Quality of life on imatinib

Elizabeth A. Hahn, G.Alastair Glendenning

Journal:

Seminars in Hematology

Year:

2003

Language:

english

File:

PDF, 137 KB

english, 2003